Skip to main content

Advertisement

Log in

Longitudinal Study of Bone Mineral Density in Patients with Crohn's Disease

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Osteoporosis is frequent in Crohn's disease. The aim of the study was to assess the rate of bone loss over time retrospectively and the influence of disease-related factors on bone loss. Twenty-nine patients (8 male), admitted for repeated bone mineral density assessments (BMD) were enrolled. BMD measured by dual energy x-ray absoptiometry was expressed in grams per square centimeter, and as sex- and age-matched Z score. The mean interval between BMD assessments was 41 months, during which period 27 patients used corticosteroids (mean dose 8.6 g) and 21 patients some form of bone protective medication. Initial Z scores at a mean age of 41 years were significantly below zero (spine −1.6 ± 1.4; femur −1.4 ± 1.4). Over time, no change in absolute BMD was observed accompanied by an improvement in Z scores. At the same time, an increase in body weight and a decrease in erythrocyte sedimentation rate (ESR) was observed. Multilinear regression analysis demonstrated change in ESR as independent predictor for change in femoral Z score. In conclusion, low BMD is frequent in Crohn's disease, but decline of BMD over time was not found, despite ongoing use of corticosteroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MacDonald BR, Gowen M: Cytokines and bone. Br J Rheumatol 31:149-155, 1992

    Google Scholar 

  2. Vogelsang H, Ferenci P, Woloszczuk W, Resch H, Herold C, Frotz S, Gangl A: Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 34:1094-1099, 1989

    Google Scholar 

  3. Andreassen H, Hylander E, Rix M: Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol 94:824-828, 1999

    Google Scholar 

  4. Kelsey JL: Risk factors for osteoporosis and associated fractures. Public Health Rep 104(suppl)14-20, 1989

    Google Scholar 

  5. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJ: Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 119:1203-1208, 2000

    Google Scholar 

  6. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, Amor B, Couturier D: Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 5:156-160, 1995

    Google Scholar 

  7. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, Compston JE: A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 23:95-104, 1993

    Google Scholar 

  8. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S: Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 32:226-232, 1997

    Google Scholar 

  9. Laskey MA, Crisp AJ, Cole TJ, Compston JE: Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy x-ray absorptiometers. Br J Radiol 65:1124-1129, 1992

    Google Scholar 

  10. Laan RF, Buijs WC, Verbeek AL, Draad MP, Corstens FH, van-de-Putte LB, van-Riel PL: Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 52:21-26, 1993

    Google Scholar 

  11. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE: Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 29:1332-1336, 1988

    Google Scholar 

  12. Clements D, Motley RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, Compston JE: Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 27:1055-1060, 1992

    Google Scholar 

  13. Schulte C, Dignass AU, Mann K, Goebell H: Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 34:696-702, 1999

    Google Scholar 

  14. Ghosh S, Cowen S, Hannan WJ, Ferguson A: Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107:1031-1039, 1994

    Google Scholar 

  15. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH: Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 8:87-92, 2002

    Google Scholar 

  16. Cino M, Greenberg GR: Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 97:915-921, 2002

    Google Scholar 

  17. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F: Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 10:250-256, 1995

    Google Scholar 

  18. Bjarnason I, Macpherson A, Mackintosh C, Buxton Thomas M, Forgacs I, Moniz C: Reduced bone density in patients with inflammatory bowel disease. Gut 40:228-233, 1997

    Google Scholar 

  19. Reed CA, Nichols DL, Bonnick SL, DiMarco NM: Bone Mineral Density and Dietary Intake in Patients with Crohn's Disease. J Clin Densitom 1:33-40, 1998

    Google Scholar 

  20. de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH: Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 97:2011-2015, 2002

    Google Scholar 

  21. Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 20:629-650, 1994

    Google Scholar 

  22. Robinson RJ, al-Azzawi F, Iqbal SJ, Kryswcki T, Almond L, Abrams K, Mayberry JF: Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 43:2500-2506, 1998

    Google Scholar 

  23. Jahnsen J, Falch JA, Aadland E, Mowinckel P: Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 40:313-319, 1997

    Google Scholar 

  24. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK: A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37:71-76, 1995

    Google Scholar 

  25. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J: Osteoporosis in patients with inflammatory bowel disease. Gut 28:410-415, 1987

    Google Scholar 

  26. Pigot F, Roux C, Chaussade S, Hardelin D, Pelleter O, Du Puy Montbrun T, Listrat V, Dougados M, Couturier D, Amor B: Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 37:1396-1403, 1992

    Google Scholar 

  27. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D: Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 93:1483-1490, 1998

    Google Scholar 

  28. Kanis JA: Calcium requirements for optimal skeletal health in women. Calcif Tissue Int 49(suppl):S33-S41, 1991

    Google Scholar 

  29. Chevalley T, Rizzoli R, Nydegger V, Slosman D, Rapin CH, Michel JP, Vasey H, Bonjour JP: Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 4:245-252, 1994

    Google Scholar 

  30. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ: Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 98:331-335, 1995

    Google Scholar 

  31. Silvennoinen J, Lamberg Allardt C, Karkkainen M, Niemela S, Lehtola J: Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 240:285-292, 1996

    Google Scholar 

  32. Silvennoinen J: Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 239:131-137, 1996

    Google Scholar 

  33. Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R: Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol 102:44-49, 1994

    Google Scholar 

  34. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G: Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 92:1157-1163, 1997

    Google Scholar 

  35. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292-299, 1998

    Google Scholar 

  36. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste ML, Tererhouse A, Chines M: Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382-387, 1997

    Google Scholar 

  37. Haderslev KV, Tjellesen L, Sorensen HA, Staun M: Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 119:639-646, 2000

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Jong, D., Mannaerts, L., van Rossum, L. et al. Longitudinal Study of Bone Mineral Density in Patients with Crohn's Disease. Dig Dis Sci 48, 1355–1359 (2003). https://doi.org/10.1023/A:1024171529000

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024171529000

Navigation